CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

Purpose We tested the hypotheses that CHEK2*1100delC heterozygosity is associated with increased risk of early death, breast cancer-specific death, and risk of a second breast cancer in women with a first breast cancer. Patients and Methods From 22 studies participating in the Breast Cancer Associa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Weischer, Maren (VerfasserIn) , Burwinkel, Barbara (VerfasserIn) , Marmé, Frederik (VerfasserIn) , Sohn, Christof (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 29, 2012
In: Journal of clinical oncology
Year: 2012, Jahrgang: 30, Heft: 35, Pages: 4308-4316
ISSN:1527-7755
DOI:10.1200/JCO.2012.42.7336
Online-Zugang:Verlag, Volltext: https://doi.org/10.1200/JCO.2012.42.7336
Verlag, Volltext: https://ascopubs.org/doi/10.1200/JCO.2012.42.7336
Volltext
Verfasserangaben:Maren Weischer, Børge G. Nordestgaard, Paul Pharoah, Manjeet K. Bolla, Heli Nevanlinna, Laura J. van't Veer, Montserrat Garcia-Closas, John L. Hopper, Per Hall, Irene L. Andrulis, Peter Devilee, Peter A. Fasching, Hoda Anton-Culver, Diether Lambrechts, Maartje Hooning, Angela Cox, Graham G. Giles, Barbara Burwinkel, Annika Lindblom, Fergus J. Couch, Arto Mannermaa, Grethe Grenaker Alnæs, Esther M. John, Thilo Dörk, Henrik Flyger, Alison M. Dunning, Qin Wang, Taru A. Muranen, Richard van Hien, Jonine Figueroa, Melissa C. Southey, Kamila Czene, Julia A. Knight, Rob A.E.M. Tollenaar, Matthias W. Beckmann, Argyrios Ziogas, Marie-Rose Christiaens, Johanna Margriet Collée, Malcolm W.R. Reed, Gianluca Severi, Frederik Marme, Sara Margolin, Janet E. Olson, Veli-Matti Kosma, Vessela N. Kristensen, Alexander Miron, Natalia Bogdanova, Mitul Shah, Carl Blomqvist, Annegien Broeks, Mark Sherman, Kelly-Anne Phillips, Jingmei Li, Jianjun Liu, Gord Glendon, Caroline Seynaeve, Arif B. Ekici, Karin Leunen, Mieke Kriege, Simon S. Cross, Laura Baglietto, Christof Sohn, Xianshu Wang, Vesa Kataja, Anne-Lise Børresen-Dale, Andreas Meyer, Douglas F. Easton, Marjanka K. Schmidt, Stig E. Bojesen

MARC

LEADER 00000caa a2200000 c 4500
001 1665269448
003 DE-627
005 20220816151023.0
007 cr uuu---uuuuu
008 190513s2012 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.2012.42.7336  |2 doi 
035 |a (DE-627)1665269448 
035 |a (DE-599)KXP1665269448 
035 |a (OCoLC)1341212671 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weischer, Maren  |e VerfasserIn  |0 (DE-588)1181810035  |0 (DE-627)1662374100  |4 aut 
245 1 0 |a CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer  |c Maren Weischer, Børge G. Nordestgaard, Paul Pharoah, Manjeet K. Bolla, Heli Nevanlinna, Laura J. van't Veer, Montserrat Garcia-Closas, John L. Hopper, Per Hall, Irene L. Andrulis, Peter Devilee, Peter A. Fasching, Hoda Anton-Culver, Diether Lambrechts, Maartje Hooning, Angela Cox, Graham G. Giles, Barbara Burwinkel, Annika Lindblom, Fergus J. Couch, Arto Mannermaa, Grethe Grenaker Alnæs, Esther M. John, Thilo Dörk, Henrik Flyger, Alison M. Dunning, Qin Wang, Taru A. Muranen, Richard van Hien, Jonine Figueroa, Melissa C. Southey, Kamila Czene, Julia A. Knight, Rob A.E.M. Tollenaar, Matthias W. Beckmann, Argyrios Ziogas, Marie-Rose Christiaens, Johanna Margriet Collée, Malcolm W.R. Reed, Gianluca Severi, Frederik Marme, Sara Margolin, Janet E. Olson, Veli-Matti Kosma, Vessela N. Kristensen, Alexander Miron, Natalia Bogdanova, Mitul Shah, Carl Blomqvist, Annegien Broeks, Mark Sherman, Kelly-Anne Phillips, Jingmei Li, Jianjun Liu, Gord Glendon, Caroline Seynaeve, Arif B. Ekici, Karin Leunen, Mieke Kriege, Simon S. Cross, Laura Baglietto, Christof Sohn, Xianshu Wang, Vesa Kataja, Anne-Lise Børresen-Dale, Andreas Meyer, Douglas F. Easton, Marjanka K. Schmidt, Stig E. Bojesen 
264 1 |c October 29, 2012 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.05.2019 
520 |a Purpose We tested the hypotheses that CHEK2*1100delC heterozygosity is associated with increased risk of early death, breast cancer-specific death, and risk of a second breast cancer in women with a first breast cancer. Patients and Methods From 22 studies participating in the Breast Cancer Association Consortium, 25,571 white women with invasive breast cancer were genotyped for CHEK2*1100delC and observed for up to 20 years (median, 6.6 years). We examined risk of early death and breast cancer-specific death by estrogen receptor status and risk of a second breast cancer after a first breast cancer in prospective studies. Results CHEK2*1100delC heterozygosity was found in 459 patients (1.8%). In women with estrogen receptor-positive breast cancer, multifactorially adjusted hazard ratios for heterozygotes versus noncarriers were 1.43 (95% CI, 1.12 to 1.82; log-rank P = .004) for early death and 1.63 (95% CI, 1.24 to 2.15; log-rank P < .001) for breast cancer-specific death. In all women, hazard ratio for a second breast cancer was 2.77 (95% CI, 2.00 to 3.83; log-rank P < .001) increasing to 3.52 (95% CI, 2.35 to 5.27; log-rank P < .001) in women with estrogen receptor-positive first breast cancer only. Conclusion Among women with estrogen receptor-positive breast cancer, CHEK2*1100delC heterozygosity was associated with a 1.4-fold risk of early death, a 1.6-fold risk of breast cancer-specific death, and a 3.5-fold risk of a second breast cancer. This is one of the few examples of a genetic factor that influences long-term prognosis being documented in an extensive series of women with breast cancer. 
700 1 |a Burwinkel, Barbara  |d 1969-  |e VerfasserIn  |0 (DE-588)120685760  |0 (DE-627)704924005  |0 (DE-576)292337752  |4 aut 
700 1 |a Marmé, Frederik  |d 1974-  |e VerfasserIn  |0 (DE-588)132561972  |0 (DE-627)52394893X  |0 (DE-576)299226549  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 30(2012), 35, Seite 4308-4316  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer 
773 1 8 |g volume:30  |g year:2012  |g number:35  |g pages:4308-4316  |g extent:9  |a CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer 
856 4 0 |u https://doi.org/10.1200/JCO.2012.42.7336  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://ascopubs.org/doi/10.1200/JCO.2012.42.7336  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190513 
993 |a Article 
994 |a 2012 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 62 
998 |g 132561972  |a Marmé, Frederik  |m 132561972:Marmé, Frederik  |d 910000  |d 910400  |e 910000PM132561972  |e 910400PM132561972  |k 0/910000/  |k 1/910000/910400/  |p 41 
998 |g 120685760  |a Burwinkel, Barbara  |m 120685760:Burwinkel, Barbara  |d 910000  |d 910400  |e 910000PB120685760  |e 910400PB120685760  |k 0/910000/  |k 1/910000/910400/  |p 18 
999 |a KXP-PPN1665269448  |e 347543993X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"313116962","id":{"zdb":["2005181-5"],"issn":["1527-7755"],"eki":["313116962"]},"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology"}],"origin":[{"dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"pubHistory":["1.1983 -"],"disp":"CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerJournal of clinical oncology","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"part":{"text":"30(2012), 35, Seite 4308-4316","issue":"35","year":"2012","pages":"4308-4316","extent":"9","volume":"30"},"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}]}],"recId":"1665269448","physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Maren Weischer, Børge G. Nordestgaard, Paul Pharoah, Manjeet K. Bolla, Heli Nevanlinna, Laura J. van't Veer, Montserrat Garcia-Closas, John L. Hopper, Per Hall, Irene L. Andrulis, Peter Devilee, Peter A. Fasching, Hoda Anton-Culver, Diether Lambrechts, Maartje Hooning, Angela Cox, Graham G. Giles, Barbara Burwinkel, Annika Lindblom, Fergus J. Couch, Arto Mannermaa, Grethe Grenaker Alnæs, Esther M. John, Thilo Dörk, Henrik Flyger, Alison M. Dunning, Qin Wang, Taru A. Muranen, Richard van Hien, Jonine Figueroa, Melissa C. Southey, Kamila Czene, Julia A. Knight, Rob A.E.M. Tollenaar, Matthias W. Beckmann, Argyrios Ziogas, Marie-Rose Christiaens, Johanna Margriet Collée, Malcolm W.R. Reed, Gianluca Severi, Frederik Marme, Sara Margolin, Janet E. Olson, Veli-Matti Kosma, Vessela N. Kristensen, Alexander Miron, Natalia Bogdanova, Mitul Shah, Carl Blomqvist, Annegien Broeks, Mark Sherman, Kelly-Anne Phillips, Jingmei Li, Jianjun Liu, Gord Glendon, Caroline Seynaeve, Arif B. Ekici, Karin Leunen, Mieke Kriege, Simon S. Cross, Laura Baglietto, Christof Sohn, Xianshu Wang, Vesa Kataja, Anne-Lise Børresen-Dale, Andreas Meyer, Douglas F. Easton, Marjanka K. Schmidt, Stig E. Bojesen"]},"id":{"eki":["1665269448"],"doi":["10.1200/JCO.2012.42.7336"]},"title":[{"title":"CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer","title_sort":"CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer"}],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"October 29, 2012"}],"note":["Gesehen am 13.05.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"role":"aut","given":"Maren","display":"Weischer, Maren","family":"Weischer"},{"family":"Burwinkel","display":"Burwinkel, Barbara","role":"aut","given":"Barbara"},{"display":"Marmé, Frederik","family":"Marmé","role":"aut","given":"Frederik"},{"display":"Sohn, Christof","family":"Sohn","given":"Christof","role":"aut"}]} 
SRT |a WEISCHERMACHEK21100D2920